BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30949832)

  • 1. The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.
    Baratelli C; Turco CGC; Lacidogna G; Sperti E; Vignani F; Marino D; Zichi C; De Luca E; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M
    Support Care Cancer; 2019 Dec; 27(12):4697-4704. PubMed ID: 30949832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
    Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06).
    Strasser F; Blum D; von Moos R; Cathomas R; Ribi K; Aebi S; Betticher D; Hayoz S; Klingbiel D; Brauchli P; Haefner M; Mauri S; Kaasa S; Koeberle D;
    Ann Oncol; 2016 Feb; 27(2):324-32. PubMed ID: 26646758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial.
    Klafke N; Mahler C; von Hagens C; Uhlmann L; Bentner M; Schneeweiss A; Mueller A; Szecsenyi J; Joos S
    Cancer Med; 2019 Jul; 8(8):3666-3676. PubMed ID: 31115192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer patients' understanding of longitudinal EORTC QLQ-C30 scores presented as bar charts.
    Loth FL; Holzner B; Sztankay M; Bliem HR; Raoufi S; Rumpold G; Giesinger JM
    Patient Educ Couns; 2016 Dec; 99(12):2012-2017. PubMed ID: 27506581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.
    Benze G; Nauck F; Alt-Epping B; Gianni G; Bauknecht T; Ettl J; Munte A; Kretzschmar L; Gaertner J
    Ann Palliat Med; 2019 Apr; 8(2):104-111. PubMed ID: 29156896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
    Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer.
    Draeger DL; Sievert KD; Hakenberg OW
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1215-e1220. PubMed ID: 30201215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients.
    Marino D; Baratelli C; Guida G; Turco CGC; Lacidogna G; Sperti E; Vignani F; De Luca E; Zichi C; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M
    Recenti Prog Med; 2020 Dec; 111(12):740-748. PubMed ID: 33362171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of overall quality of life in preterminal cancer patients.
    Beijer S; Kempen GI; Pijls-Johannesma MC; de Graeff A; Dagnelie PC
    Int J Cancer; 2008 Jul; 123(1):232-5. PubMed ID: 18412247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe symptoms and very low quality-of-life among outpatients newly diagnosed with advanced cancer: data from a multicenter cohort study.
    Siemens W; Schönsteiner SS; Orellana-Rios CL; Schaekel U; Kessler J; Eschbach C; Viehrig M; Mayer-Steinacker R; Becker G; Gaertner J
    Support Care Cancer; 2020 Nov; 28(11):5547-5555. PubMed ID: 32185557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life trajectory in patients with advanced cancer during the last year of life.
    Giesinger JM; Wintner LM; Oberguggenberger AS; Gamper EM; Fiegl M; Denz H; Kemmler G; Zabernigg A; Holzner B
    J Palliat Med; 2011 Aug; 14(8):904-12. PubMed ID: 21711125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
    Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
    Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported perceptions of care after the introduction of a new advanced cancer nursing role in Sweden.
    Westman B; Ullgren H; Olofsson A; Sharp L
    Eur J Oncol Nurs; 2019 Aug; 41():41-48. PubMed ID: 31358256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer.
    Bedard G; Zeng L; Zhang L; Lauzon N; Holden L; Tsao M; Danjoux C; Barnes E; Sahgal A; Poon M; Chow E
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):109-17. PubMed ID: 23551530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom concerns and quality of life in hepatobiliary cancers.
    Sun V; Ferrell B; Juarez G; Wagman LD; Yen Y; Chung V
    Oncol Nurs Forum; 2008 May; 35(3):E45-52. PubMed ID: 18467279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.
    Holländer-Mieritz C; Johansen J; Johansen C; Vogelius IR; Kristensen CA; Pappot H
    Acta Oncol; 2019 May; 58(5):603-609. PubMed ID: 30698098
    [No Abstract]   [Full Text] [Related]  

  • 20. A longitudinal analysis of patient satisfaction with care and quality of life in ambulatory oncology based on the OUT-PATSAT35 questionnaire.
    Nguyen TV; Anota A; Brédart A; Monnier A; Bosset JF; Mercier M
    BMC Cancer; 2014 Jan; 14():42. PubMed ID: 24460858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.